AI is finally cracking rare disease diagnosis and that could save years of searching
EvORanker, a new AI tool reported in March 2026, can identify the correct disease-causing gene as the top candidate in nearly 70 percent of clinical rare disease cases and within the top five in 95 percent, potentially cutting years off the diagnostic process for hundreds of millions of patients worldwide.